Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Vicore Pharma in connection with a directed share issue of approximately SEK 185 million
Mandate

Vinge has advised Vicore Pharma in connection with a directed share issue of approximately SEK 185 million

July 08, 2020 Capital Markets and Public M&A

Vinge has advised Vicore Pharma, a Swedish rare disease company focused on interstitial lung diseases and related indications, in connection with a directed share issue whereby Vicore Pharma will receive approximately SEK 185 million in issue proceeds.

The subscription price was determined to SEK 18.50 per share through an accelerated book building process. The share issue was directed to a number of Swedish and international institutional investors. The main purpose of the share issue is to finance Vicore Pharma’s development of current and future product candidates.

Vinge’s team consisted of Jesper Schönbeck, Rikard Lindahl, William Kåge and Clara Sohlberg.

 

Related

Vinge has advised BAE Systems Bofors on the acquisition of Aston Harald Mekaniska Verkstad

 BAE Systems is a world-leading defence group with a presence in Sweden through, among others, BAE Systems Bofors in Karlskoga, a supplier of weapon systems, artillery and ammunition. The acquisition is strategically motivated and aims to strengthen the Swedish defence industry's production capacity.
February 12, 2026

Vinge has advised Sertion AB in connection with the acquisition of Svensk Anläggning och Driftteknik AB

 Through the acquisition, Sertion takes a further step in its development as a leading international infrastructure and installation group within complex HVAC systems, technical infrastructure, and industrial piping. Svensk Anläggning och Driftteknik AB specializes in certified welding and installation of industrial piping.
February 10, 2026

Vinge advises Mirova in connection with the acquisition of the Boarp, Dållebo and Fågelås wind farms

 Vinge has advised Mirova, a subsidiary of Natixis Investment Managers focusing on sustainable investments, in connection with the acquisition of the three Swedish onshore wind farms Boarp, Dållebo and Fågelås.
February 10, 2026